A new flavonoid glycoside, 5,7,4´-trihydroxy-3,6-dimethoxyflavone-3´-O-β-D-xylopyranoside (axillarin-3´-O-β-Dxylopyranoside), was isolated from the ethyl acetate fraction of the ethanolic extract of Platanus orientalis L. leaves, along with nine known flavonoid aglycones and glycosides, a phenolic acid and a phenolic acid derivative. Their structures were established on the basis of detailed spectral analysis. The total ethanolic, aqueous and ethyl acetate extracts of the leaves were tested for antihepatotoxic, antioxidant and cytotoxic activities. The extracts were found to be effective in protection against CCl 4 liver injury by significantly lowering alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP) levels. The extracts also significantly restored depleted levels of glutathione, indicating a strong antioxidant activity, while they showed variable cytotoxic activity.
Many
phytochemicals, especially phenolic constituents, have shown promise for the protection and/or treatment of hepatotoxicity cases in which oxidative stress plays a key role [1] [2] [3] . Platanus orientalis L., known as oriental plane (family Platanaceae), is a deciduous tree native to south-west Asia, south-east Europe and the Mediterranean regions [4, 5] . The leaves were used in folk medicine in opthalmia, the bark was boiled in vinegar and given for diarrhea, dysentery and toothache [6, 7] , while the buds were used as a urinary tract antiseptic and antimicrobial [8] . Only one report has been found dealing with the flavonoidal content of the buds and their cytotoxic activity [9] . Nothing could be traced concerning either the phytochemical content or biological activities of the leaves.
This work reports the isolation of a new flavonoid glycoside, 5,7,4´-trihydroxy-3,6dimethoxyflavone-3´-O-β-xylopyranoside (axillarin-3´-O-β-xylopyranoside) (1), in addition to nine known flavonoid aglycones and glycosides (2-10), a phenolic acid (11) , and a phenolic acid derivative (12) . Also, the antihepatotoxic, antioxidant and cytotoxic activities of the total ethanolic extract (TEE), total aqueous extract (TAE), and the flavonoid-rich ethyl acetate fraction (EAF) were evaluated and reported.
Compound 1 was obtained as a yellow powder. The molecular formula was calculated as C 22 H 22 O 12 from the ESI-MS [M-H]molecular ion peak appearing at m/z 477. A peak observed at m/z 345 after ionization indicated the loss of a pentose sugar. The NMR spectra suggested a flavonoid skeleton for the compound. The 1 H NMR spectrum showed signals of ring B (2 doublets at δ 6.99, d, J = 8.4 Hz and δ 7.83, d, J = 2.1 Hz) indicating ortho and meta couplings of protons 5´ and 2´ with H-6´, respectively. This was confirmed by a doublet of doublets assigned to H-6´ (δ 7.65, dd, J = 8.4, 2.1 Hz). The downfield shift of H-2´ (0.7 ppm) indicates the presence of a substituent at the 3´position [10, 11] . In addition, ring A protons were represented by a singlet at δ 6.52, assigned to H-8. The absence of other signals characteristic of ring A suggested substitution at the 3 and 6 positions, with the two methoxyl groups displayed at δ 3.80 and 3.74, respectively. The anomeric proton of the sugar unit appeared as a doublet at δ 4.79. This upfield shift, together with its coupling constant (J = 6.9 Hz), confirmed the sugar attachment to be at the 3´ position having a β-configuration [10, 11] . All the 13 C NMR signals were assigned and the sugar moiety was identified as β-xylopyranoside by comparison with reported data [12] . The HMBC experiment showed correlations between δ 4.79 (H-1´´) and 144.9 (C-3´), between δ 3.74 (CH 3 -6) and 131.2 (C-6) and between δ 3.80 (CH 3 -3) and 137.3 (C-3). Thus, compound 1 was identified
Compounds 2-12 were identified as kaempferol (2), (10) , p-coumaric acid (11) , and 4´caffeoylquinic acid (cryptochlorogenic acid) (12) by comparing their UV, 1 H and 13 C NMR spectroscopic data with those published [10, [12] [13] [14] [15] [16] [17] [18] . Toxicological studies revealed that the LD 50 of both the TEE and TAE of P. orientalis leaves were 7.3 and 7.6 g/kg, respectively and can be considered safe [19] .
The antioxidant activity was determined in alloxaninduced diabetic rats [20] . All the extracts restored the depleted levels of glutathione (GSH) ( Table 1) with the EAF being the most potent extract (93.8%).
The tested extracts reversed the elevated levels of the serum liver enzymes alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP) ( Table 2 ). These effects were comparable to and in some cases higher than that of the reference drug, silymarin. TEE was the most potent extract as it decreased the levels of ALT, AST and ALP by 52.7%, 43% and 39%, respectively.
All the tested extracts showed dose dependent cytotoxicity against the three human cancer cell lines, MCF7, HEPG2 and H460 (Table 3 ). It was observed that EAF showed the highest activity against HEPG2 cell line. This result, in addition to its potent antioxidant activity and its ability to lower the elevated levels of the liver enzymes could be attributed to its phenolic content. 
Extraction and isolation:
The air dried, powdered and defatted leaves of P. orientalis (2 kg) were macerated with 70% EtOH till exhaustion. The ethanolic extract was evaporated under reduced pressure to give 197 g of dark green residue, of which 180 g was suspended in water (600 mL) and partitioned successively with CHCl 3 , EtOAc and n-BuOH to afford 22 g, 25 g and 13 g of dried residues, respectively.
Another 100 g of the air dried, powdered leaves was boiled with 500 mL water, followed by evaporation under reduced pressure. The residue was dissolved in sterile water before administration to rats.
EAF (20 g Fractions 5 (950 mg), 6 (3.1 g), 7 (3.2 g), 8 (2 g) and 9 (1.5 g) were purified on Sephadex LH-20 followed by CC on silica gel 60 and Silica gel C 18 -reversed phase to give compounds 6 (22 mg, 0.11%), 1 (30 mg, 0.15%), 7 (23 mg, 0.11%), 8 (32 mg, 0.16%), 9 (20 mg, 0.1%), 10 (35 mg, 0.17%) and 12 (32 mg, 0.16%). 
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